| scholarly article | Q13442814 |
| P50 | author | Carmine Zoccali | Q5043714 |
| Peter Paul van Dijk | Q19843721 | ||
| Renée de Mutsert | Q47157594 | ||
| Friedo W. Dekker | Q50946862 | ||
| Kitty J Jager | Q90059065 | ||
| P2860 | cites work | Risk factor paradox in wasting diseases | Q36847437 |
| Logical and statistical fallacies in the use of Cox regression models | Q40961986 | ||
| Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis | Q44683546 | ||
| Body size and outcomes on peritoneal dialysis in the United States | Q47440216 | ||
| Causes and consequences of the reverse epidemiology of body mass index in dialysis patients | Q57772193 | ||
| Confounding: What it is and how to deal with it | Q58948757 | ||
| Left Atrial Volume Monitoring and Cardiovascular Risk in Patients with End-Stage Renal Disease: A Prospective Cohort Study | Q58949257 | ||
| Left atrial volume in end-stage renal disease: a prospective cohort study | Q58949660 | ||
| Association between Body Mass Index and Mortality Is Similar in the Hemodialysis Population and the General Population at High Age and Equal Duration of Follow-Up | Q59361749 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 994-997 | |
| P577 | publication date | 2008-07-16 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Survival analysis: time-dependent effects and time-varying risk factors. | |
| P478 | volume | 74 |
| Q91894418 | "Spatial heterogeneity of environmental risk in randomized prevention trials: consequences and modeling" |
| Q36459372 | All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients |
| Q64103461 | Association Between Serum High-Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: Results From the KNOW-CKD |
| Q33692733 | Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons |
| Q93074822 | Association of Abdominal Adiposity with Cardiovascular Mortality in Incident Hemodialysis |
| Q38274831 | Association of cardiovascular health screening with mortality, clinical outcomes, and health care cost: a nationwide cohort study |
| Q35442156 | Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients |
| Q55512228 | Beneficial effect of statins in patients receiving chronic hemodialysis following percutaneous coronary intervention: A nationwide retrospective cohort study. |
| Q33797543 | Benefit of kidney transplantation beyond 70 years of age |
| Q36555035 | Body size and longitudinal body weight changes do not increase mortality in incident peritoneal dialysis patients of the Brazilian peritoneal dialysis multicenter study |
| Q39510086 | Both low and high serum ferritin levels predict mortality risk in hemodialysis patients without inflammation. |
| Q27305816 | Cell-based screening: extracting meaning from complex data |
| Q51758616 | Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy. |
| Q36306782 | Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study |
| Q38762804 | Current state of clinical end-points assessment in transplant: Key points |
| Q44265372 | Daily protein intake and survival in patients on peritoneal dialysis |
| Q36566858 | Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation |
| Q47108714 | Determination of the optimal target level of proteinuria in the management of patients with glomerular diseases by using different definitions of proteinuria |
| Q90410558 | Developmental considerations in survival models as applied to substance use research |
| Q89678121 | Diabetes pay-for-performance program can reduce all-cause mortality in patients with newly diagnosed type 2 diabetes mellitus |
| Q34202707 | Effect of diuretic use on 30-day postdialysis mortality in critically ill patients receiving acute dialysis |
| Q36201538 | Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension |
| Q89675895 | Eosinophil count and mortality risk in incident hemodialysis patients |
| Q36066296 | Estimating the risk of type-2 diabetes using obese-years in a contemporary population of the Framingham Study |
| Q90628530 | Factors associated with disease progression in dogs with presumed preclinical degenerative mitral valve disease attending primary care veterinary practices in the United Kingdom |
| Q92514600 | Factors pertaining to long-term mortality following emergency visits for head and neck cancer |
| Q35043215 | Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study |
| Q52686641 | High-Sensitivity Troponin T and C-Reactive Protein Have Different Prognostic Values in Hemo- and Peritoneal Dialysis Populations: A Cohort Study. |
| Q36315868 | Hypomagnesemia and Mortality in Incident Hemodialysis Patients |
| Q64947673 | Hyponatremia in the Dialysis Population. |
| Q30422457 | Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure |
| Q89052564 | Inverse Association Between Serum Non-High-Density Lipoprotein Cholesterol Levels and Mortality in Patients Undergoing Incident Hemodialysis |
| Q26865220 | Longitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative disease |
| Q54385634 | Low cholesterol in dialysis patients--causal factor for mortality or an effect of confounding? |
| Q37848040 | Monitoring of inflammation in patients on dialysis: forewarned is forearmed |
| Q24318474 | Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies |
| Q88141204 | Obesity and Kidney Disease: Hidden Consequences of the Epidemic |
| Q88712257 | Obesity and Kidney Disease: Hidden Consequences of the Epidemic |
| Q30235506 | Obesity and Kidney Disease: Hidden Consequences of the Epidemic |
| Q87702635 | Obesity and kidney disease: Hidden consequences of the epidemic |
| Q52720558 | Obesity and kidney disease: Hidden consequences of the epidemic. |
| Q57771331 | Obesity and kidney disease: hidden consequences of the epidemic |
| Q88363993 | Obesity and kidney disease: hidden consequences of the epidemic |
| Q95481087 | Obesity and kidney disease: hidden consequences of the epidemic |
| Q52906732 | Obesity and kidney disease: hidden consequences of the epidemic. |
| Q53081563 | Obesity and kidney disease: hidden consequences of the epidemic. |
| Q53347632 | Obesity and kidney disease: hidden consequences of the epidemic. |
| Q35758572 | Obesity and mortality risk among younger dialysis patients |
| Q40057240 | Obesity and risk of death or dialysis in younger and older patients on specialized pre-dialysis care |
| Q36926918 | Pre-dialysis serum sodium and mortality in a national incident hemodialysis cohort |
| Q53112773 | Pregnancy in women with immunoglobulin A nephropathy: are obstetrical complications associated with renal prognosis? |
| Q39515844 | Prognostic value of pulmonary hypertension in patients undergoing surgery for degenerative mitral valve disease with leaflet prolapse |
| Q44442646 | Psychotropic drug use in community-dwelling elderly people-characteristics of persistent and incident users |
| Q64111012 | Reply to critical comments on the article 'Increased risk of developing psychiatric disorders in children with attention deficit and hyperactivity disorder (ADHD) receiving sensory integration therapy: a population-based cohort study' |
| Q99616664 | Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development |
| Q94673534 | Residual Urine Output and Mortality in a Prospective Hemodialysis Cohort |
| Q35883947 | Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors |
| Q36270634 | Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery--development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. |
| Q37520876 | Serum potassium levels and its variability in incident peritoneal dialysis patients: associations with mortality |
| Q40674576 | Serum sodium and mortality in a national peritoneal dialysis cohort |
| Q37176793 | Similar survival on automated peritoneal dialysis and continuous ambulatory peritoneal dialysis in a large prospective cohort |
| Q90359895 | Sleep duration and risk of end-stage renal disease: the Singapore Chinese Health Study |
| Q40079037 | Statistical Methods for Modeling Time-Updated Exposures in Cohort Studies of Chronic Kidney Disease |
| Q30411453 | Survival advantage in black versus white men with CKD: effect of estimated GFR and case mix. |
| Q30790979 | Survival analysis of time-to-event data in respiratory health research studies |
| Q61822253 | Temporal trends in relative survival following percutaneous coronary intervention |
| Q98178858 | The Impact of Race and Ethnicity Upon Health-Related Quality of Life and Mortality in Dialysis Patients |
| Q33559174 | The choice of self-rated health measures matter when predicting mortality: evidence from 10 years follow-up of the Australian longitudinal study of ageing |
| Q37218725 | The effect of hospital care on early survival after penetrating trauma |
| Q31145556 | Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study |
| Q39489616 | Thyroid Functional Disease and Mortality in a National Peritoneal Dialysis Cohort |
| Q57771217 | Thyroid Status and Death Risk in US Veterans With Chronic Kidney Disease |
| Q40282601 | Thyroid Status and Mortality in a Prospective Hemodialysis Cohort |
| Q53631266 | Uric acid and the risk of graft failure in kidney transplant recipients: a re-assessment. |
Search more.